FindTrial
Sign In

Study on the efficacy and safety of five in one therapy for graded treatment of haemophilic arthritis and characters of hemophilia arthropathy

Study on the efficacy and safety of five in one therapy for graded treatment of haemophilic arthritis and characters of hemophilia arthropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPN-16008563
Enrollment
Unknown
Registered
2016-05-30
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilic arthritis

Interventions

Test group:Five in one therapy
Control group:Using FVIII / FIX

Sponsors

Shaanxi Yida Hemophilia Institute affiliated Xi’an Xincheng Yida Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 85 Years

Inclusion criteria

Inclusion criteria: Test group: 1. Meet the clinical-defined hemophilia arthritis criteria; 2. Agree to use five in one therapy for graded treatment of haemophilic arthritis during the experiment;3.sign informed conset. Control group: 1. Meet the clinical-defined hemophilia arthritis criteria; 2. Agree to use recombinant coagulation factor during the experiment; 3. sign informed conset.

Exclusion criteria

Exclusion criteria: 1. Patients with hemorrhagic disease of non-hemophlia such as von willebrand disease and secondary recombinant FVIII /FIX deficiency; 2. Rheumatic arthritis,rheumatoid arthritis and tuberculous arthritis; 3. Drug allergies; 4. Incomplete personal information.

Design outcomes

Primary

MeasureTime frame
Articular swelling;Pain;Tenderness;Joint activity;—

Secondary

MeasureTime frame
recent and long-term remission rates;Long-term remission rate, recurrence and disability rate;—

Countries

China

Contacts

Public ContactLiu Shanxi

Shaanxi Yida Hemophilia Institute affiliated Xi'an Xincheng Yida Hospital

13992821100@139.com+86 15091331100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026